Wound Debridement Procedure Note

Date/Time: [Date and start time of procedure]

Location: [Clinic / Bedside / ED / OR / Other]

Operator: [Name, credentials]

Assistants: [Names and roles / None]

Procedure Summary

[Procedure performed] — [Number] wound(s): [Anatomic locations with laterality]. Anesthesia/analgesia: [Medication(s) and route / No anesthesia used]. Outcome: [Patient tolerance], hemostasis [achieved / not achieved], complications [none / description]. (Keep to 1–4 concise lines for quick scan.)

Indication

[Wound etiology/type and stage/classification if applicable]. Debridement indicated today due to [specific findings observed on exam: necrotic tissue, slough, eschar, stalled healing, bioburden/biofilm, infection risk, preparation for advanced therapy]. (Link indication explicitly to wound characteristics seen today; avoid generic statements.)

Pre-Procedure

• Consent: [Written / Verbal] informed consent obtained; risks, benefits, and alternatives discussed; patient agreed to proceed.
• Time-Out: Time-out performed confirming correct patient, procedure, and site(s).
• Pertinent factors:
  • Allergies (anesthetic/adhesive): [List / None]
  • Anticoagulant/antiplatelet use: [Agent(s) and last dose / None]
  • Baseline pain score (0–10): [Value]
  • Vascular status (lower extremity wounds): [Perfusion assessment—pulses, capillary refill, ABI/TBI if available]

Wound Assessment and Debridement

(Repeat this wound block for each wound debrided. Use consistent wound identifiers across visits. Clearly distinguish total wound measurements from surface area actually debrided. If any measurement cannot be safely obtained, document the reason and provide the best alternative such as photograph reference or prior measurement with date.)

Wound #[Identifier] — [Anatomic location with laterality]

Pre-Debridement Assessment:

• Wound type/etiology and stage/classification: [Description]
• Measurements (pre): [Length] × [Width] × [Depth] cm; Area: [Value] cm²
• Undermining/Tunneling: [Absent / Present: extent in cm and clock-face location]
• Wound bed: [Percentage necrotic/slough/eschar]; exudate [amount and character]; odor [present / absent]
• Periwound: [Maceration / Erythema / Callus / Edema / Intact / Other]
• Infection signs: [Absent / Present: specific findings]

Debridement Performed:

• Type: [Sharp selective / Sharp excisional / Mechanical / Hydrosurgical / Other]
• Instruments: [Curette / Scalpel / Scissors / Forceps / Hydrosurgical device / Other]
• Tissue removed: [Slough / Fibrin / Eschar / Callus / Biofilm / Necrotic tissue] at [tissue level]
• Deepest level of viable tissue reached: [Epidermis / Dermis / Subcutaneous tissue / Fascia / Muscle / Bone]
• Surface area actually debrided: [Value] cm² (extent of devitalized tissue removed, distinct from total wound size)
• Endpoint: [Viable bleeding tissue / Punctate bleeding / Improved wound bed visualization / Other]
• Anesthesia: [Medication, concentration, dose/volume, route / No anesthesia used]
• Prep/Technique: [Cleansing solution]; [Sterile / Clean] technique; Irrigation [solution and volume / None]

Post-Debridement Status:

• Measurements (post): [Length] × [Width] × [Depth] cm; Area: [Value] cm²
• Wound bed: [Updated description—granulation, viable tissue, remaining necrotic tissue if any]
• Pain score after procedure (0–10): [Value / Not assessed]

(For coding: Sum surface areas debrided within each depth category for wounds at the same depth. Keep measurements and totals separate by depth for wounds at different depths.)

Hemostasis and Blood Loss

Bleeding: [None / Minimal / Moderate / Brisk]. Hemostasis method: [Direct pressure / Chemical cautery / Topical hemostatic agent / Suturing / Not required]. Estimated blood loss: [Value in mL / Minimal, not measured].

Specimens

(Include only if specimens obtained; otherwise omit or state "No specimens obtained" per local preference.)

[Specimen type] from [source wound and location within wound], sent to [Microbiology / Pathology] for [tests ordered]. Rationale: [Suspected infection / Osteomyelitis concern / Atypical wound / Other].

Complications

[No complications / Complication(s): description and management]. (An explicit statement is required even if none occurred.)

Dressing and Wound Care Plan

• Primary dressing: [Type and specifics]
• Secondary dressing: [Type and specifics]
• Topical agents: [Agent and indication / None]
• Packing (if undermining/tunnels present): [Material and technique / Not applicable]
• Offloading/Compression/Pressure redistribution: [Plan specific to wound etiology / Not applicable]
• Dressing change frequency: [Frequency] by [Patient / Caregiver / Home health / Clinic]
• Infection management (if applicable): [Antibiotic(s) with dose and duration / Culture pending / Not indicated]

Disposition and Follow-Up

• Tolerance: [Patient tolerated procedure well / Issues encountered]; pain control [adequate / inadequate].
• Disposition: [Stable, ambulatory / Returned to unit / Other].
• Follow-up: Return in [interval]. Escalation instructions: [Return precautions given including worsening pain, fever, spreading erythema, increased drainage/odor, uncontrolled bleeding]. Next planned interventions: [Repeat debridement / Advanced therapy consideration / Imaging / Referral / Routine follow-up].

Signature

Electronically signed by [Name, credentials] on [Date/time]. Photographs: [Obtained and stored per policy / Not obtained].

(Meta-instructions: Ensure all required elements are present—wound location, pre- and post-debridement measurements, deepest tissue level removed, surface area debrided, anesthesia documentation, hemostasis, explicit complications statement, dressing plan, and follow-up. If information is missing from dictation, insert "[Not documented]" rather than omitting the field. Clearly distinguish total wound dimensions from surface area of tissue actually debrided. Do not infer medical necessity from diagnosis alone; indication must reference specific wound findings observed.)